SCHEMBL17276375

SCHEMBL17276375

COc1cc(-c2cnn(C(=O)N3CCCC3)c2)ccc1-c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ GAK O14976 1/20 0.43
▸ DAGLB Q8NCG7 2/20 0.43
▸ KMT2A Q03164 1/20 0.41
▸ ROCK2 O75116 3/20 0.41
▸ DAGLA Q9Y4D2 2/20 0.40
▸ NR2F2 P24468 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ CASP1 P29466 1/20 0.40
▸ CASP7 P55210 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ HTR2B P41595 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17276798 0.88 DAGLA (0.46) KMT2ADAGLAALDH1A1HPGDMAPK1
SCHEMBL17276552 0.82 HPGD (0.51) KMT2AALDH1A1HPGDTSHRMAPK1
SCHEMBL17276373 0.81 HPGD (0.49) KMT2AALDH1A1HPGDTSHRMAPK1
SCHEMBL17276563 0.80 HPGD (0.47) KMT2AKDM4EALDH1A1HPGDMAPK1
SCHEMBL17276713 0.75 ALDH1A1 (0.55) KMT2AKDM4EALDH1A1SMN1; SMN2POLB
SCHEMBL17276646 0.75 NPC1 (0.43) KMT2ATSHRPOLB
SCHEMBL19078697 0.74 CCNC (0.39) ALDH1A1TSHR
SCHEMBL17276317 0.73 NPC1 (0.44) ALDH1A1HPGDTSHRSMN1; SMN2
SCHEMBL17276663 0.73 PLA2G7 (0.46) KMT2AALDH1A1TSHRSMN1; SMN2POLB
SCHEMBL19078765 0.72 FAAH (0.53) KMT2AKDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015179559-A2 PYRAZOLE COMPOUNDS AND METHODS OF MAKING AND USING SAME ABIDE THERAPEUTICS, INC. (US) 2015-11-26 — — WO disclosed
Send feedback